The Widespread Expression of Angiogenin in Different Human Cells Suggests a Biological Function not only Related to Angiogenesis

Angiogenin is a secreted polypeptide that induces neovascularization in vivo. The expression of angiogenin by human cells in culture was investigated by using a specific radioimmunoassay and by cDNA hybridization. Angiogenin immunoreactivity was widely but differentially produced by anchorage‐dependent growing cells including vascular endothelial cells from saphenous and umbilical veins, aortic smooth muscle cells, fibroblasts (from embryos, new‐borns and adults), and tumour cells. Endothelial cells from saphenous veins and the endothelium‐derived EA.hy926 cell line released immunoreactivity whatever the stage of the culture, including release at the lag phase, during exponential growth and at the confluent phase. However, the rate of accumulation of angiogenin varied as a function of EA.hy926 cell density. As compared to anchored cells, normal peripheral blood cells and tumour cells of myelomonocytic and megakaryocytic origin did not noticeably secrete angiogenin except at low levels. A myeloma cell line supernatant contained as much angiogenin cross‐reactivity as did anchored cells, while four tumour T‐cell lines expressed the cross‐reactivity at different levels, i.e. from undetectable levels to a high level. A 0.9‐kb angiogenin messenger RNA was detected by Northern‐blot analyses in a variety of representative cells correlating with the presence of immunoreactivity in the cell‐culture media. The widespread expression pattern of angiogenin suggests a physiological function that is not restricted to the neovascularization process.